NAVA SWITCH LNP Trademark

Trademark Overview

On Thursday, November 20, 2025, a trademark application was filed for NAVA SWITCH LNP with the United States Patent and Trademark Office. The USPTO has given the NAVA SWITCH LNP trademark a serial number of 99507745. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, May 4, 2026. This trademark is owned by Nava Therapeutics, Inc.. The NAVA SWITCH LNP trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, lipids for drug delivery and research; pharmaceutical preparations, namely, nanoparticles for use in gene therapy, drug delivery, medical research; pharmaceutical preparations, namely, lipid nanoparticles; pharmaceutical preparations, namely, lipid nanoparticles for the delivery of nucleic acid-based therapeutics; pharmaceutical preparations, namely, targeted lipid nanoparticles
nava switch lnp

General Information

Serial Number99507745
Word MarkNAVA SWITCH LNP
Filing DateThursday, November 20, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, May 4, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2026

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, lipids for drug delivery and research; pharmaceutical preparations, namely, nanoparticles for use in gene therapy, drug delivery, medical research; pharmaceutical preparations, namely, lipid nanoparticles; pharmaceutical preparations, namely, lipid nanoparticles for the delivery of nucleic acid-based therapeutics; pharmaceutical preparations, namely, targeted lipid nanoparticles

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 20, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNava Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
US

Trademark Events

Event DateEvent Description
Thursday, November 20, 2025NEW APPLICATION ENTERED
Thursday, November 20, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, November 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 26, 2026ASSIGNED TO EXAMINER
Friday, March 27, 2026NON-FINAL ACTION WRITTEN
Friday, March 27, 2026NON-FINAL ACTION E-MAILED
Friday, March 27, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 23, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 23, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 23, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 27, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 20, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

switch nava pharmaceutical namely preparations nanoparticles lipid delivery research drug targeted based